专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20130096193A1 CREATINE BETA-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE 审中-公开
标题翻译：新西兰BETA-ALANINATE：一种提高性能的新型盐
公开(公告)号：US20130096193A1
公开(公告)日：2013-04-18
申请号：US13691172
申请日：2012-11-30
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： C07C279/14
CPC分类号： C07C279/14 , A23K20/142 , A23K50/20 , A23K50/40 , A23L33/175 , A23V2002/00 , A61K31/197 , C07C229/08 , A23V2250/306 , A23V2200/33 , A23V2200/316 , A23V2250/0628 , A23V2250/0612 , A23V2250/314 , A23V2250/0644 , A23V2250/062 , A23V2250/0652 , A23V2250/506 , A23V2250/636 , A23V2250/061
摘要： Disclosed are creatine β-alaninate, compositions and formulations containing same, and methods of use therefor.
摘要翻译：公开了肌酸β-丙氨酸酯，含有其的组合物和制剂及其使用方法。

2. 发明申请

US20120010291A1 CREATINE Beta-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE 审中-公开
标题翻译： CREATINE Beta-ALANINATE：一种用于增加性能的新型盐
公开(公告)号：US20120010291A1
公开(公告)日：2012-01-12
申请号：US12811623
申请日：2009-08-12
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/198 , A61P17/00 , A61P21/00 , C07C251/02 , C07C249/02
CPC分类号： C07C279/14 , A23K20/142 , A23K50/20 , A23K50/40 , A23L33/175 , A23V2002/00 , A61K31/197 , C07C229/08 , A23V2250/306 , A23V2200/33 , A23V2200/316 , A23V2250/0628 , A23V2250/0612 , A23V2250/314 , A23V2250/0644 , A23V2250/062 , A23V2250/0652 , A23V2250/506 , A23V2250/636 , A23V2250/061
摘要： Disclosed are creatine β-alaninate, compositions and formulations containing same, and methods of use therefor.
摘要翻译：公开的是肌酸和布拉宁，含有其的组合物和制剂及其使用方法。

3. 发明申请

US20100119499A1 STILBENE-BASED COMPOSITIONS AND METHODS OF USE THEREFOR 审中-公开
标题翻译：基于STILBENE的组合物及其使用方法
公开(公告)号：US20100119499A1
公开(公告)日：2010-05-13
申请号：US12687962
申请日：2010-01-15
申请人： Bruce W. Kneller , Daniel C. Pierce , Joseph Babick, JR.
发明人： Bruce W. Kneller , Daniel C. Pierce , Joseph Babick, JR.
IPC分类号： A61K38/43 , A61K31/075 , A61K31/195 , A61K38/16
CPC分类号： A61K31/075 , A61K31/195
摘要： Disclosed are compositions, formulations and methods relating to one or more stilbene-based compounds for use in humans. In particular, compositions and formulations comprising an effective amount of the stilbene-based insulinogenic compound can improve athletic performance, lower blood glucose levels, and increase lean muscle mass when administered (e.g., orally) to a human.
摘要翻译：公开了与用于人类的一种或多种芪类化合物有关的组合物，制剂和方法。特别地，包含有效量的基于二苯乙烯的胰岛素生成化合物的组合物和制剂可以改善运动性能，降低血糖水平，并且当向人施用（例如，口服）时增加瘦肌肉质量）。

4. 发明申请

US20200237791A1 PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY 审中-公开
公开(公告)号：US20200237791A1
公开(公告)日：2020-07-30
申请号：US16785498
申请日：2020-02-07
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/7016 , A61K9/00 , A61K38/05 , A61K33/00 , A61K31/197 , A61K31/7076 , A61K31/70 , A61K45/06 , A61K31/566 , A61K31/122
摘要： The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

5. 发明申请

US20110218244A1 CREATINE ß-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE 审中-公开
标题翻译： CREATINEß-ALANINATE：用于增加性能的新型盐
公开(公告)号：US20110218244A1
公开(公告)日：2011-09-08
申请号：US13108896
申请日：2011-05-16
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/223 , A61P21/00 , A61P17/00
CPC分类号： C07C279/14 , A23L33/175 , A61K31/221 , C07C229/08
摘要： Disclosed are creatine β-alaninate, compositions and formulations containing same, and methods of use therefor.
摘要翻译：公开的是肌酸和布拉宁，含有其的组合物和制剂及其使用方法。

6. 发明申请

US20090306031A1 5alpha-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR 审中-公开
标题翻译： 5α-ANDROSTANE-3,6,17-TRIONE（KNELLER'S TRIONE）及其使用方法
公开(公告)号：US20090306031A1
公开(公告)日：2009-12-10
申请号：US12541608
申请日：2009-08-14
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/5685 , C07J1/00
CPC分类号： A61K31/5685
摘要： Disclosed are compounds such as 5α-androstane-3,6,17-trione, formulations comprising said compounds, and methods of use thereof to stimulate endogenous testosterone production and improve athletic performance and libido.
摘要翻译：公开了诸如5α-雄甾烷-3,6,17-三酮的化合物，包含所述化合物的制剂及其用于刺激内源性睾酮产生并改善运动表现和性欲的方法。

7. 发明授权

US11103522B2 Palatinose for enhancing dietary supplement and pharmaceutical delivery 有权
公开(公告)号：US11103522B2
公开(公告)日：2021-08-31
申请号：US16785498
申请日：2020-02-07
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/7016 , A61K9/00 , A61K31/122 , A61K31/197 , A61K31/566 , A61K31/70 , A61K31/7076 , A61K33/00 , A61K38/05 , A61K45/06
摘要： The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

8. 发明申请

US20170340657A1 PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY 审中-公开
公开(公告)号：US20170340657A1
公开(公告)日：2017-11-30
申请号：US15666528
申请日：2017-08-01
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/7016 , A61K38/05 , A61K33/00 , A61K31/70 , A61K9/00 , A61K31/566 , A61K31/197 , A61K31/122 , A61K45/06 , A61K31/7076
CPC分类号： A61K31/7016 , A61K9/0019 , A61K31/122 , A61K31/197 , A61K31/566 , A61K31/70 , A61K31/7076 , A61K33/00 , A61K38/05 , A61K45/06
摘要： The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

9. 发明申请

US20130095125A1 PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY 审中-公开
标题翻译： PALATINOSE用于增强膳食补充和药物输送
公开(公告)号：US20130095125A1
公开(公告)日：2013-04-18
申请号：US13709763
申请日：2012-12-10
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/7016 , A61K31/122 , A61K33/00 , A61K31/566 , A61K31/7076 , A61K31/197 , A61K31/70 , A61K38/05 , A61K45/06
CPC分类号： A61K31/7016 , A61K9/0019 , A61K31/122 , A61K31/197 , A61K31/566 , A61K31/70 , A61K31/7076 , A61K33/00 , A61K38/05 , A61K45/06
摘要： The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound.
摘要翻译：本发明涉及包含帕拉金糖或其衍生物的膳食补充剂。膳食补充剂可以是营养产品，运动性能产品，减肥产品或膳食替代产品。本发明还涉及增加化合物进入血流，细胞和组织的吸收的方法，包括与化合物组合施用帕拉金糖或其衍生物。

10. 发明授权

US07939517B2 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses 失效
标题翻译： 1,4,6-雄烯三烯-3,17-二酮（“ATD”）用于治疗用途
公开(公告)号：US07939517B2
公开(公告)日：2011-05-10
申请号：US11187043
申请日：2005-07-22
申请人： Bruce W. Kneller
发明人： Bruce W. Kneller
IPC分类号： A61K31/56 , A61K31/5685
CPC分类号： A61K31/57
摘要： A composition having at least one modified or derivative of 1,4,6-androstatriene-3,17-dione (“ATD”) will improve the health of mammalian subjects. The improvement of health is achieved with the administration of an effective amount of at least one modified or derivative of 1,4,6-androstatriene-3,17-dione. Particularly, health is improved for a subject suffering with a gynecomastia and/or estrogen-dependent cancer. Also, subjects recovering from steroid misuse/abuse will benefit from treatment in accordance with the present invention.
摘要翻译：具有至少一种1,4,6-雄烯三烯-3,17-二酮（“ATD”）的修饰或衍生物的组合物将改善哺乳动物受试者的健康。通过施用有效量的至少一种1,4,6-雄烯三烯-3,17-二酮的修饰或衍生物来实现健康的改善。特别是，对于患有男子乳房发育症和/或雌激素依赖性癌症的受试者而言，健康状况得到改善。此外，从类固醇滥用/滥用中恢复的受试者将受益于根据本发明的治疗。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式